Supreme Court initiates suo motu case on need to speed up hearing in matters on life saving drugs

Abstract
The Supreme Court of India has initiated a suo motu case to address delays in hearing matters related to access to life-saving drugs, including patented medicines. This move comes after a letter was sent to the Chief Justice highlighting the plight of a cancer patient who died while her petition was pending before the Kerala High Court for over two years. The Supreme Court has issued notice in the matter and may lay down pan-India guidelines to ensure timely adjudication of such life-and-liberty matters.
Introduction
The Supreme Court's decision to initiate a suo motu case on the need to speed up hearing in matters related to access to life-saving drugs is a significant development in the Indian legal landscape. The move comes in response to a letter sent by the Working Group on Access to Medicines and Treatment, highlighting the delays in a particular case before the Kerala High Court. This article will examine the background of this issue, its significance, and the potential implications for the legal profession.
Background
The Indian Constitution guarantees the right to life under Article 21, which has been interpreted by the Supreme Court to include access to essential medicines. However, delays in hearing matters related to life-saving drugs have become a persistent problem in India's judicial system. The Kerala High Court's handling of the case mentioned in the letter is a stark example of this issue, with the matter being heard by eight different judges over several years without a final decision being taken.
Analysis
The Supreme Court's suo motu case is a welcome move to address the delays in hearing matters related to access to life-saving drugs. The court's potential laying down of pan-India guidelines to ensure timely adjudication of such cases is a significant step towards ensuring that the right to life under Article 21 is protected. However, the issue of delays in India's judicial system is complex and multifaceted, and it remains to be seen how effective these guidelines will be in addressing this problem. The Supreme Court's decision also raises questions about the role of the judiciary in protecting access to essential medicines and the need for greater coordination between different courts and tribunals.
Conclusion
The Supreme Court's suo motu case on the need to speed up hearing in matters related to access to life-saving drugs is a significant development that highlights the importance of timely adjudication of such cases. Practitioners should be aware of this development and its potential implications for their practice, particularly in cases involving access to essential medicines. The outcome of this matter has not yet been reported, but it is expected to have far-reaching consequences for the legal profession and the protection of human rights in India.
How does this affect your business?
Get an AI analysis of this article grounded in your jurisdictions, practice areas, and any policy documents you've uploaded to Wansom.
